Resolution hit by FCA review

Resolution shares are down following the Financial Conduct Authority’s investigation into ‘unfair’ insurance policies.

Resolution is trading at 297p, down 7%, after the FCA announced it will investigate claims that insurance firms had unfair terms and charges attached to their financial products, dating as far back as the 1970 until the 2000s.

The FCA will begin its investigation in the summer which will look into the terms and conditions of over 30 million products such as pensions, endowments and life insurance.

The insurance sector as a whole has taken a hit this morning but the investigation will focus on so called zombie funds. Resolution has considerably more exposure to zombie funds and that is why the company has been hit harder today.

The stock has lost nearly nine months of gains in one trading session. If the company is liable for lawsuits it could be a colossal amount and this has traders worried. The stock traded as low as 267p today, but it has managed to pull back some of its losses with the 50-period moving average of 313p acting as a resistance level.

Resolution chart

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.